Skip to content

Genesis 104

by Neurofield, Inc.

Genesis 104 is a medical device (FDA Class II; FDA product code QJQ, Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety) made by Neurofield, Inc., cleared under FDA 510(k) K252951 on 31 Dec 2025 and listed in FDA GUDID since 7 May 2026 (UDI-DI 00860010064634), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K252951

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860010064634 UDI-DI Date7 May 2026ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK252951 Date31 Dec 2025DecidedStatusActive

Official records

From the FDA record

Device description
Genesis Sleep is a non-invasive transdermal neurostimulation device to treat chronic insomnia. The device utilizes a technology known as electrical vestibular nerve stimulation (VeNS). It is indicated for clinical- and home-use to treat chronic insomnia in adults aged 22 and older. It consists of a battery-powered device designed to transcutaneously deliver low-level electrical energy (up to 1 mA) to the skin behind the ears, over the mastoid processes. The delivery of this neurostimulation is through two single-use self-adhesive electrode pads. These pads are placed on the skin behind each ear (mastoid area). The intensity of the electric pulse can be adjusted up or down by the user. When turned on, the device delivers a small electrical impulse which stimulates the vestibular nerve. When the device is not being used, the battery can be charged using the charging station provided. Therefore, it is not physically possible to recharge the battery while the device is in use in stimulation mode. The Genesis Sleep device exerts its therapeutic effect through electrical stimulation of the vestibular nerves. Electrical vestibular nerve stimulation (VeNS) is a non-invasive therapeutic method that applies pulsed, alternating microcurrent transcutaneously to the vestibular nerves via stimulation pads. Genesis Sleep delivers this neurostimulation through two self-adhesive stimulation pads which are placed on the skin behind each ear (mastoid processes). When turned on, the device delivers a small electrical impulse which can be adjusted up or down by the user.
MRI safety
MR Unsafe
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K252951 decided 31 Dec 2025 Active
  • FDA GUDID UDI-DI 00860010064634 listed 7 May 2026 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K252951
  2. Listed FDA GUDID 00860010064634

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Genesis
Generic name
Psychiatric/stress-therapy periauricular nerve transcutaneous electrical stimulation system
Model / reference
104
Primary DI / UDI-DI
00860010064634
510(k) Number
FDA product code
QJQ
GMDN term
Psychiatric/stress-therapy periauricular nerve transcutaneous electrical stimulation system
Device class
Class II
Regulation number
882.5800
GUDID distribution status
In Commercial Distribution
MRI safety
MR Unsafe

Similar devices

Other devices filed under FDA product code QJQ (Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety).

Other devices from Neurofield, Inc.

  • Q21 169

    Class II
  • NeuroField X3000 17

    Not classified
  • Q21

    Class II
  • Genesis Sleep

    Class II

See all devices from Neurofield, Inc. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)